US FDA guidance explains how to display proprietary and established drug names in promotional material
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued final guidance for prescription drug manufacturers clarifying how they may display the proprietary and established names of drug products in promotional materials, including advertisements disseminated via social media websites1,2.